In addition to evaluation of tumor tissue biopsy specimens, ERBB2 amplification can be identified by non-invasive methods [9], including assessment of ERBB2 overexpression in circulating tumor cells or measurement of ERBB2 copy numbers via NGS of cell-free DNA. This evidence concerns the gene ERBB2 and neoplasm.